Your session is about to expire
← Back to Search
Care Partner Assessment Tool for Dementia
N/A
Recruiting
Led By Beth Fields, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours post-discharge
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at whether a care partner questionnaire can help people with dementia get better care when they leave the hospital. Care partners of hospitalized dementia patients take part in the trial for 14 days.
Who is the study for?
This trial is for adult care partners who provide unpaid assistance to a hospitalized relative or partner with Alzheimer's disease or related dementias (ADRD). Participants must be over 18 and speak English. It's not suitable for those who cannot communicate in English.
What is being tested?
The study is testing the CHAT-AD, an assessment tool designed to improve post-hospital care for people with dementia. Care partners will use this questionnaire to help ensure better ongoing care once the patient returns home from the hospital.
What are the potential side effects?
Since this trial involves using a questionnaire tool rather than medication, there are no direct medical side effects. However, participants may experience emotional or psychological stress while discussing sensitive topics about their caregiving experiences.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours post-discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours post-discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Care partner satisfaction of care
Change in Preparedness for Caregiving
Secondary study objectives
Change in care partner burden
Change in care partner depression
Feasibility measure: Implementation satisfaction
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Adjusted CHAT-ADExperimental Treatment1 Intervention
Using CHAT, participants will be asked questions about their needs to fully support and care for their loved one after the loved one is released from the hospital.
Group II: Standard of CareActive Control1 Intervention
Participants in this arm will only receive standard of care.
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,172,495 Total Patients Enrolled
23 Trials studying Dementia
13,080 Patients Enrolled for Dementia
University of Wisconsin, MadisonLead Sponsor
1,237 Previous Clinical Trials
3,200,851 Total Patients Enrolled
8 Trials studying Dementia
1,708 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,803 Previous Clinical Trials
28,194,383 Total Patients Enrolled
296 Trials studying Dementia
23,635,412 Patients Enrolled for Dementia
Beth Fields, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak English.I am 18 years old or older.I am an unpaid caregiver for a relative or partner with ADRD in the hospital.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: Adjusted CHAT-AD
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.